Underdiagnosed chronic obstructive pulmonary disease in England: New country, same story

Thorax

Volumn 61, Issue 12, 2006, Pages 1032-1034

  Mannino, D M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DIAGNOSTIC ERROR; DISEASE SEVERITY; DRUG TOLERANCE; EDITORIAL; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOKING CESSATION; UNITED KINGDOM;

DIAGNOSTIC ERRORS; ENGLAND; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 33845215783     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.067785     Document Type: Editorial

References (23)

1. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9.
2. Kim DS, Kim YS, Chung KS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-7.
3. Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis, and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006;61:1043-7.
4. Pauwels RA, Buist AS, Calverley PM, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
5. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005;60:842-7.
6. Hansen EF, Phanareth K, Laursen LC, et al. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1267-71.
7. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1,075 outpatients with asthma. Chest 1995;108:10-5.
8. Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003;58:388-93.
9. Mannino DM, Doherty DE, Sonia BA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100:115-22.
10. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax 2006;61:472-7.
11. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9.
12. Buist AS. Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes. Eur Respir J Suppl 2003;39:30-5s.
13. Sin DD, Wu L, Anderson JA, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005;60:992-7.
14. Vestbo J. The TORCH (Towards a Revolution in COPD Health) survival study protocol. Eur Respir J 2004;24:206-10.
15. Celik P, Sakar A, Havlucu Y, et al. Short-term effects of montelukast in stable patients with moderate to severe COPD. Respir Med 2005;99:444-50.
16. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden studies. Respir Med 2003;97:115-22.
17. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, et al. Women and smoking: a report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, 2001.
18. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, et al. The health consequences of smoking: a report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, 2004.
19. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, et al. Reducing tobacco use: a report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, 2000.
20. 1: the Lung Health Study. JAMA 1994;272:1497-505.
21. Willemse BW, Poslma DS, Timens W, et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004;23:464-76.
22. Hnizdo E, Sullivan PA, Bang KM, et al. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;156:738-46.
23. Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003;22:462-9.